Professor Dai’s discovery has made a significant contribution to the field of tumor immunotherapy, offering new hope for patients. In our hospital, immunotherapy is typically applied in combination with other minimally invasive techniques. For patients with advanced-stage cancer, combined immunotherapy can greatly improve treatment efficacy, extending survival time and enhancing quality of life. When used for individuals with a family history of cancer or a previous cancer diagnosis, it can also aid in immune reconstruction, helping to prevent tumor formation and inhibit malignant transformation.

Compared to Western medicine, Traditional Chinese Medicine places greater emphasis on a holistic approach and the principle of syndrome differentiation and treatment. Professor Yin, with 40 years of clinical experience in TCM internal medicine, excels in using TCM’s holistic perspective and personalized treatment to enhance the effects of radiotherapy and chemotherapy, reducing toxicity and improving the quality of life for cancer patients. As a TCM specialist at our hospital, Professor Yin is also a member of our MDT. He is involved throughout the treatment and rehabilitation process for international cancer patients—from admission to discharge and follow-up. His contributions have significantly extended the survival period and improved the quality of life for cancer patients.

The treatment of high-risk tumors, such as intracranial tumors, has long been a clinical challenge. With the advancement of minimally invasive therapies, our hospital has made significant progress in managing tumors in high-risk areas. We offer 18 advanced international minimally invasive anti-cancer technologies, including the seed implantation technique used by Professor He Jianyu, as well as drug-loaded microsphere embolization therapy, the Combined knife, and more. Additionally, our hospital has adopted an innovative “integrated Chinese and Western medicine with minimally invasive targeting” approach to cancer treatment. We believe that in the future, we can bring hope and relief to even more cancer patients.

In tumor treatment, our hospital’s minimally invasive interventional therapies are widely used for cancers such as gastric and colorectal cancer due to their advantages of avoiding removal and having minimal side effects. Professor Song Shijun, our hospital’s Chief Oncology Expert, has also accumulated extensive experience in diagnosing and treating malignant tumors of the digestive system and is highly skilled in managing various clinical emergencies in oncology.

Immunotherapy has achieved certain successes in treating clinical tumor patients, and Professor Zhou Shengtao’s recent discoveries have undoubtedly advanced the field of tumor immunotherapy. In practical tumor treatment applications, our hospital typically integrates immunotherapy with minimally invasive techniques. We primarily use non-resection, non-radiotherapy, and non-chemotherapy minimally invasive methods—such as interventional therapy and seed implantation—to effectively control tumor progression while eliminating the tumor. This is supplemented with immunotherapy to boost the patient’s immune system, inhibit cancer cell proliferation, and significantly extend patients’ survival time and quality of life.

As the training base for Integrative Oncology Medicine under the “Belt and Road” initiative of the China Anti-Cancer Association, our hospital adopts an MDT collaborative consultation model, bringing together doctors from various specialties, including Traditional Chinese Medicine expert Professor Yin Pingshan, to provide comprehensive and personalized treatment for patients. Taking lung cancer treatment as an example, minimally invasive techniques focus on tumor control and elimination, while Professor Yin uses Traditional Chinese Medicine to assist cancer patients in “solidifying the foundation and nourishingthe origin.” The combination of Chinese and Western medicine works in tandem, resulting in significant therapeutic outcomes for lung cancer patients.

Professor Li Wenbin’s research has overcome clinical application bottlenecks and greatly advanced the development of the industry. Regarding precision treatment for lung cancer, early molecular pathology diagnosis is essential, and subsequent treatment methods are even more critical. Professor Song Shijun, Chief Expert of the Oncology Department at our hospital and a certified expert in lung cancer by the China Anti-Cancer Association, has accumulated extensive clinical experience in precision lung cancer treatment. For most lung cancer patients, seed implantation therapy, which is highly accurate, non-resective, safe, effective, and minimally invasive, is one of the preferred treatment options. In addition to lung cancer, seed implantation therapy is also applicable to other solid tumors, such as breast cancer, liver cancer, and nasopharyngeal cancer.

Professor Zhao Hongyun’s team’s research findings significantly improve tumor treatment outcomes and advance new drug development. Integrative medicine plays a role in new drug development and treatment methods. Our hospital adopts a new anti-cancer model of “integrating Chinese and Western medicine with minimally invasive targeting” to treat cancer. This approach combines 18 advanced international minimally invasive anti-cancer techniques with traditional Chinese medicine, achieving precise tumor elimination while minimizing treatment side effects and improving patients’ quality of life.

Improving quality of life is one of the core goals of integrative oncology care. Our hospital’s MDT consistently advocates the concept of “early prevention and early treatment” for cancer care. In addition to providing personalized treatment plans and one-stop diagnosis and treatment services, we also offer value-added medical services such as inpatient meal services, one-on-one nutritionist guidance, post-operative rehabilitation support, and follow-up care after treatment. We strive to provide patients with peace of mind and comfort, aiming to maximize their quality of life.

Cancer science popularization is an important means to improve public health and reduce the burden of cancer. As the “Belt and Road” Integrative Oncology Training Base (Guangdong) of the China Anti-Cancer Association, our hospital has been rooted in China and open to the world since its establishment in 2005. We have set up more than 10 international service centers in Southeast Asia. Each year, our MDT expert team conducts over 50 in-person seminars across Southeast Asia, promoting cancer prevention and treatment knowledge while sharing the latest international minimally invasive cancer therapies. Healthcare knows no borders—helping cancer patients in Southeast Asia and around the world overcome suffering is our hospital’s enduring duty and mission.